SEARCH

SEARCH BY CITATION

FilenameFormatSizeDescription
resp12009-sup-0001-si.docx17K

Table S1 Mean value change from baseline and treatment comparison for ACQ scores between patients receiving budesonide/formoterol maintenance and reliever therapy and those receiving budesonide/formoterol plus terbutaline.

Table S2 Incidence of the most common (>2%) adverse events.

Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.